We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Gilead Announces Phase I Data for an Investigational Compound for the Treatment of Chronic Hepatitis C

News   Nov 05, 2007

 
Gilead Announces Phase I Data for an Investigational Compound for the Treatment of Chronic Hepatitis C
 
 
 

RELATED ARTICLES

Scorpion Venom Can Shuttle Drugs into the Brain

News

Researchers at IRB Barcelona modify chlorotoxin—a small protein present in scorpion venom with blood-brain barrier permeability—to transport drugs into the brain.

READ MORE

Biopatch Delivers Exact Drug Doses Directly into Cells

News

Minimally invasive patch developed by Purdue researchers delivers exact doses directly into cells, lessens pain and toxicity.

READ MORE


 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE